FDA approves Qiagen’s TB blood test: 3 things to know

The Food and Drug Administration on Thursday approved Qiagen’s fourth generation tuberculosis blood test.

Advertisement

Here are three things to know.

  1. The Quantiferon-TB Gold Plus test is designed to detect latent tuberculosis in patients.
  1. The blood test offers a broad look into an individual’s immune response to tuberculosis, according to a news release.
  1. Qiagen plans to launch the new test later this year.

More articles on supply chain:

7 drugmakers in the headlines
4 ways hospitals can lower inpatient drug costs
6 must-reads for supply chain leaders this week

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.